{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:10Z","timestamp":1791404470685,"version":"4.3.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chemotherapy for hepatoblastoma is limited by organ toxicity and poor outcomes, prompting the search for new, more effective treatments with minimal side effects. Vincristine sulfate, a potent chemotherapeutic, faces challenges due to P-glycoprotein-mediated resistance and its systemic toxicity. Nanoparticles offer a promising solution by improving pharmacokinetics, targeting tumor cells, thus reducing side effects. Moreover, the use of fluorescent nanomaterials is emerging in biomedical applications such as bioimaging, detection and therapies. This study describes a promising delivery system utilizing carbon dots encapsulated with vincristine in biodegradable polycaprolactone nanoparticles via a double emulsion technique. The fine characterization of these nanoparticles showed that they are spherical, uniformly sized with around 200\u00a0nm and exhibit excellent colloidal stability. Moreover, the release profile showed prolonged release for both vincristine and carbon dots. In vitro cell viability studies revealed enhanced cancer cell inhibition for the encapsulated drug compared to the vincristine solution. The uptake study indicated clear fluorescence for carbon dots solution and vincristine and carbon dots loaded nanoparticles upon excitation. Additionally, studies on primary mouse hepatocytes demonstrated higher fluorescence intensity in treatment groups. These results suggest that vincristine and carbon dots loaded nanoparticles are effective, target-specific carriers for liver cancer treatment. Furthermore, the carbon dots were not cytotoxic, highlighting their potential in bioimaging and cancer cell studies.<\/jats:p>","DOI":"10.1038\/s41598-024-75332-1","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:02:31Z","timestamp":1729256551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Polymeric nanoparticles loaded with vincristine and carbon dots for hepatocellular carcinoma therapy and imaging"],"prefix":"10.1038","volume":"14","author":[{"given":"Walaa","family":"Fawaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsamie","family":"Hanano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Yousfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alghoraibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameela","family":"Hasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"75332_CR1","doi-asserted-by":"crossref","unstructured":"Chidambaranathan-Reghupaty, S., Fisher, P. B. & Sarkar, D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. In Advances in Cancer Research, Vol. 149 (Elsevier Inc., 2021).","DOI":"10.1016\/bs.acr.2020.10.001"},{"key":"75332_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69\u201390 (2011).","journal-title":"CA Cancer J. Clin."},{"key":"75332_CR3","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.22506","volume":"48","author":"JM Llovet","year":"2008","unstructured":"Llovet, J. M. & Bruix, J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48, 1312\u20131327 (2008).","journal-title":"Hepatology"},{"key":"75332_CR4","doi-asserted-by":"crossref","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 7, (2021).","DOI":"10.1038\/s41572-020-00240-3"},{"key":"75332_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.msec.2018.08.027","volume":"93","author":"E Ahmadian","year":"2018","unstructured":"Ahmadian, E. et al. Engineering of Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line. Mater. Sci. Eng. C 93, 465\u2013471 (2018).","journal-title":"Mater. Sci. Eng. C"},{"key":"75332_CR6","doi-asserted-by":"crossref","unstructured":"Zhong, L. et al. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal. Transduct. Target. Ther. 6 (2021).","DOI":"10.1038\/s41392-021-00572-w"},{"key":"75332_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life11010071","volume":"11","author":"S Al-Musawi","year":"2021","unstructured":"Al-Musawi, S. et al. Smart nanoformulation based on polymeric magnetic nanoparticles and vincristine drug: A novel therapy for apoptotic gene expression in tumors. Life 11, 1\u201312 (2021).","journal-title":"Life"},{"key":"75332_CR8","doi-asserted-by":"crossref","unstructured":"Triarico, S. et al. Vincristine-induced peripheral neuropathy (Vipn) in pediatric tumors: Mechanisms, risk factors, strategies of prevention and treatment. Int. J. Mol. Sci. 22, (2021).","DOI":"10.3390\/ijms22084112"},{"key":"75332_CR9","doi-asserted-by":"publisher","unstructured":"Silverman, J. A. & Deitcher, S. R. Marqibo\u00ae (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. 555\u2013564. https:\/\/doi.org\/10.1007\/s00280-012-2042-4 (2013).","DOI":"10.1007\/s00280-012-2042-4"},{"key":"75332_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"T Emran","year":"2022","unstructured":"Emran, T. et al. Multidrug resistance in cancer: Understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front. Oncol. 12, 1\u201338 (2022).","journal-title":"Front. Oncol."},{"key":"75332_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci. 7, 1\u201314 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"75332_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2021.05.012","volume":"335","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy. J. Control Release 335, 1\u201320 (2021).","journal-title":"J. Control Release"},{"key":"75332_CR13","doi-asserted-by":"crossref","unstructured":"Nocito, G. et al. Carbon dots as promising tools for cancer diagnosis and therapy. 1\u201314 (2021).","DOI":"10.3390\/cancers13091991"},{"key":"75332_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.carbon.2013.03.009","volume":"59","author":"Q Wang","year":"2013","unstructured":"Wang, Q. et al. Hollow luminescent carbon dots for drug delivery. Carbon N. Y. 59, 192\u2013199 (2013).","journal-title":"Carbon N. Y."},{"key":"75332_CR15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/cbic.201500694","volume":"17","author":"SK Bhunia","year":"2016","unstructured":"Bhunia, S. K., Maity, A. R., Nandi, S., Stepensky, D. & Jelinek, R. Imaging cancer cells expressing the folate receptor with carbon dots produced from folic acid. ChemBioChem 17, 614\u2013619 (2016).","journal-title":"ChemBioChem"},{"key":"75332_CR16","doi-asserted-by":"publisher","unstructured":"Sarkar, P., Ghosh, S. & Sarkar, K. Folic acid based Carbon dot functionalized stearic acid-g-polyethyleneimine amphiphilic nanomicelle: Targeted drug delivery and imaging for triple negative breast cancer. Colloids Surf. B Biointerfaces 111382. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111382 (2020).","DOI":"10.1016\/j.colsurfb.2020.111382"},{"key":"75332_CR17","doi-asserted-by":"publisher","first-page":"111233","DOI":"10.1016\/j.msec.2020.111233","volume":"116","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Enhanced-fluorescent imaging and targeted therapy of liver cancer using highly luminescent carbon dots-conjugated foliate. Mater. Sci. Eng. C 116, 111233 (2020).","journal-title":"Mater. Sci. Eng. C"},{"key":"75332_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cpr.12488","volume":"51","author":"T Kong","year":"2018","unstructured":"Kong, T., Hao, L., Wei, Y., Cai, X. & Zhu, B. Doxorubicin conjugated carbon dots as a drug delivery system for human breast cancer therapy. Cell. Prolif. 51, 1\u20139 (2018).","journal-title":"Cell. Prolif."},{"key":"75332_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/IJN.S229154","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Doxorubicin-loaded carbon dots lipid-coated calcium phosphate nanoparticles for visual targeted delivery and therapy of tumor. Int. J. Nanomed. 15, 433\u2013444 (2020).","journal-title":"Int. J. Nanomed."},{"key":"75332_CR20","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1021\/la400479n","volume":"29","author":"L Zhou","year":"2013","unstructured":"Zhou, L., Li, Z., Liu, Z., Ren, J. & Qu, X. Luminescent carbon dot-gated nanovehicles for ph-triggered intracellular controlled release and imaging. Langmuir 29, 6396\u20136403 (2013).","journal-title":"Langmuir"},{"key":"75332_CR21","doi-asserted-by":"publisher","first-page":"113257","DOI":"10.1016\/j.jphotochem.2021.113257","volume":"412","author":"M Rahal","year":"2021","unstructured":"Rahal, M., Atassi, Y. & Alghoraibi, I. Quenching photoluminescence of carbon quantum dots for detecting and tracking the release of minocycline. J. Photochem. Photobiol Chem. 412, 113257 (2021).","journal-title":"J. Photochem. Photobiol Chem."},{"key":"75332_CR22","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1002\/jps.22200","volume":"99","author":"XR Song","year":"2010","unstructured":"Song, X. R. et al. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma. J. Pharm. Sci. 99, 4874\u20134879 (2010).","journal-title":"J. Pharm. Sci."},{"key":"75332_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-022-00888-w","volume":"16","author":"A Fahmi","year":"2022","unstructured":"Fahmi, A., Abdur-Rahman, M., Mahareek, O. & shemis, M. A. Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system. BMC Chem. 16, 1\u201315 (2022).","journal-title":"BMC Chem."},{"key":"75332_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijpharm.2015.10.057","volume":"496","author":"M Iqbal","year":"2015","unstructured":"Iqbal, M., Zafar, N., Fessi, H. & Elaissari, A. Double emulsion solvent evaporation techniques used for drug encapsulation. Int. J. Pharm. 496, 173\u2013190 (2015).","journal-title":"Int. J. Pharm."},{"key":"75332_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.colsurfa.2006.10.048","volume":"297","author":"A Benichou","year":"2007","unstructured":"Benichou, A., Aserin, A. & Garti, N. O\/W\/O double emulsions stabilized with WPI-polysaccharide conjugates. Colloids Surf. Physicochem Eng. Asp 297, 211\u2013220 (2007).","journal-title":"Colloids Surf. Physicochem Eng. Asp"},{"key":"75332_CR26","doi-asserted-by":"crossref","unstructured":"Wang, J., Hahn, S., Amstad, E. & Vogel, N. Tailored double emulsions made simple. Adv. Mater. 34 (2022).","DOI":"10.1002\/adma.202107338"},{"key":"75332_CR27","doi-asserted-by":"crossref","unstructured":"Panigrahi, D. et al. Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles. 3, 638 (2021).","DOI":"10.1007\/s42452-021-04609-1"},{"key":"75332_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01160-4","volume":"19","author":"Y Lee","year":"2021","unstructured":"Lee, Y. et al. Rhamnolipid-coated W\/O\/W double emulsion nanoparticles for efficient delivery of doxorubicin\/erlotinib and combination chemotherapy. J. Nanobiotechnol. 19, 1\u201313 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"75332_CR29","doi-asserted-by":"crossref","unstructured":"Pulingam, T., Foroozandeh, P., Chuah, J. A. & Sudesh, K. Exploring various techniques for the chemical and biological synthesis of polymeric nanoparticles. Nanomaterials 12 (2022).","DOI":"10.3390\/nano12030576"},{"key":"75332_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/pharmaceutics13020191","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz, S., Miko\u0142ajczyk, A., B\u0142asiak, E., Fic, E. & Dziedzicka-Wasylewska, M. Polycaprolactone nanoparticles as promising candidates for nanocarriers in novel nanomedicines. Pharmaceutics 13, 191 (2021).","journal-title":"Pharmaceutics"},{"key":"75332_CR31","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1021\/acsbiomaterials.0c00163","volume":"6","author":"Q Pan","year":"2020","unstructured":"Pan, Q. et al. Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian Cancer. ACS Biomater. Sci. Eng. 6, 2175\u20132185 (2020).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"75332_CR32","doi-asserted-by":"publisher","first-page":"e10397","DOI":"10.1016\/j.heliyon.2022.e10397","volume":"8","author":"SK Hema","year":"2022","unstructured":"Hema, S. K., Karmakar, A., Das, R. K. & Srivastava, P. Simple formulation and characterization of double emulsion variant designed to carry three bioactive agents. Heliyon 8, e10397 (2022).","journal-title":"Heliyon"},{"key":"75332_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcancer.2019.11.002","volume":"69","author":"S Raj","year":"2021","unstructured":"Raj, S. et al. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Semin Cancer Biol. 69, 166\u2013177 (2021).","journal-title":"Semin Cancer Biol."},{"key":"75332_CR34","doi-asserted-by":"crossref","unstructured":"Rashed, M., Dadashzadeh, S. & Bolourchian, N. The impact of process and formulation parameters on the fabrication of Efavirenz nanosuspension to improve drug solubility and dissolution. Iran. J. Pharm. Res. 21, (2022).","DOI":"10.5812\/ijpr-129409"},{"key":"75332_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10934-020-00981-2","volume":"28","author":"M Mahmoudi","year":"2021","unstructured":"Mahmoudi, M., Saeidian, H., Mirjafary, Z. & Mokhtari, J. Preparation and characterization of memantine loaded polycaprolactone nanocapsules for Alzheimer\u2019s disease. J. Porous Mater. 28, 205\u2013212 (2021).","journal-title":"J. Porous Mater."},{"key":"75332_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jcis.2008.03.033","volume":"322","author":"F Lince","year":"2008","unstructured":"Lince, F., Marchisio, D. L. & Barresi, A. A. Strategies to control the particle size distribution of poly-\u03b5-caprolactone nanoparticles for pharmaceutical applications. J. Colloid Interface Sci. 322, 505\u2013515 (2008).","journal-title":"J. Colloid Interface Sci."},{"key":"75332_CR37","doi-asserted-by":"publisher","unstructured":"Shnoudeh, A. J. et al. Synthesis, Characterization, and Applications of Metal Nanoparticles. Biomaterials and Bionanotechnology (Elsevier Inc., 2019). https:\/\/doi.org\/10.1016\/B978-0-12-814427-5.00015-9","DOI":"10.1016\/B978-0-12-814427-5.00015-9"},{"key":"75332_CR38","doi-asserted-by":"publisher","unstructured":"Barhoum, A., Garc\u00eda-Betancourt, M. L., Rahier, H. & Van Assche, G. Physicochemical characterization of nanomaterials: Polymorph, composition, wettability, and thermal stability. In Emerging Applications of Nanoparticles and Architectural Nanostructures: Current Prospects and Future Trends (Elsevier Inc., 2018). https:\/\/doi.org\/10.1016\/B978-0-323-51254-1.00009-9.","DOI":"10.1016\/B978-0-323-51254-1.00009-9"},{"key":"75332_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18579\/jpcrkc\/2013\/12\/1\/79116","volume":"12","author":"CR Bonepally","year":"2013","unstructured":"Bonepally, C. R., Gandey, S. J., Bommineni, K., Gottumukkala, K. M. & Aukunuru, J. Preparation, characterisation and in vivo evaluation of silybin nanoparticles for the treatment of liver fibrosis. Trop. J. Pharm. Res. 12, 1\u20136 (2013).","journal-title":"Trop. J. Pharm. Res."},{"key":"75332_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ajps.2017.02.003","volume":"12","author":"N Kamaraj","year":"2017","unstructured":"Kamaraj, N., Rajaguru, P. Y., Kumar Issac, Sundaresan, S. & P. & Fabrication, characterization, in vitro drug release and glucose uptake activity of 14-deoxy, 11, 12-didehydroandrographolide loaded polycaprolactone nanoparticles. Asian J. Pharm. Sci. 12, 353\u2013362 (2017).","journal-title":"Asian J. Pharm. Sci."},{"key":"75332_CR41","unstructured":"Irshad, S. Cefotaxime loaded polycaprolactone based polymeric nanoparticles with antifouling properties for in-vitro drug release applications (2021)."},{"key":"75332_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/0118764029271070231117041624","volume":"15","author":"W Fawaz","year":"2023","unstructured":"Fawaz, W., Hasian, J. & Alghoraibi, I. Preparation, characterization, and release profile study of vincristine sulfate-loaded polycaprolactone nanoparticles. Micro Nanosyst 15, 300\u2013307 (2023).","journal-title":"Micro Nanosyst"},{"key":"75332_CR43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1039\/C8SM02189A","volume":"15","author":"K Abstiens","year":"2019","unstructured":"Abstiens, K., Maslanka Figueroa, S., Gregoritza, M. & Goepferich, A. M. Interaction of functionalized nanoparticles with serum proteins and its impact on colloidal stability and cargo leaching. Soft Matter 15, 709\u2013720 (2019).","journal-title":"Soft Matter"},{"key":"75332_CR44","doi-asserted-by":"publisher","first-page":"110816","DOI":"10.1016\/j.colsurfb.2020.110816","volume":"188","author":"M Ndumiso","year":"2020","unstructured":"Ndumiso, M. et al. Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum. Colloids Surf. B Biointerfaces 188, 110816 (2020).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"75332_CR45","unstructured":"Rawat, D. & Kumar, D. Nature of electronic transitions and factors affecting it: Woodward Fieser rules and applications of UV spectroscopy. Univ. Delhi 1\u201315 (2014)."},{"key":"75332_CR46","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10853-007-2210-9","volume":"43","author":"SM Martins-Franchetti","year":"2008","unstructured":"Martins-Franchetti, S. M., Campos, A., Egerton, T. A. & White, J. R. Structural and morphological changes in poly(caprolactone)\/poly(vinyl chloride) blends caused by UV irradiation. J. Mater. Sci. 43, 1063\u20131069 (2008).","journal-title":"J. Mater. Sci."},{"key":"75332_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-43911-2_3","volume":"0","author":"R Jelinek","year":"2017","unstructured":"Jelinek, R. Characterization and physical properties of carbon-dots. Carbon Nanostruct. 0, 29\u201346 (2017).","journal-title":"Carbon Nanostruct."},{"key":"75332_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41598-023-46084-1","volume":"13","author":"W Fawaz","year":"2023","unstructured":"Fawaz, W., Hasian, J. & Alghoraibi, I. Synthesis and physicochemical characterization of carbon quantum dots produced from folic acid. Sci. Rep. 13, 2\u20137 (2023).","journal-title":"Sci. Rep."},{"key":"75332_CR49","doi-asserted-by":"publisher","unstructured":"Jeewantha, H. A., Ivanovich, S. A. & Mihailovich, K. P. Validated spectrophotometric method & for the estimation of validated spectrophotometric method for the estimation of vincristine and. https:\/\/doi.org\/10.22159\/ijpps.2017v9i4.16577 (2017).","DOI":"10.22159\/ijpps.2017v9i4.16577"},{"key":"75332_CR50","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1016\/j.biomaterials.2012.01.052","volume":"33","author":"C Liu","year":"2012","unstructured":"Liu, C. et al. Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence. Biomaterials 33, 3604\u20133613 (2012).","journal-title":"Biomaterials"},{"key":"75332_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","volume":"200","author":"A Wicki","year":"2015","unstructured":"Wicki, A., Witzigmann, D., Balasubramanian, V. & Huwyler, J. Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications. J. Control Release 200, 138\u2013157 (2015).","journal-title":"J. Control Release"},{"key":"75332_CR52","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-natan","year":"2020","unstructured":"Charni-natan, M. & Goldstein, I. Protocol protocol for primary mouse hepatocyte isolation protocol for primary mouse hepatocyte isolation. STAR. Protoc. 1, 100086 (2020).","journal-title":"STAR. Protoc."},{"key":"75332_CR53","doi-asserted-by":"crossref","unstructured":"Feng, M., Divall, S. & Wu, S. An Improved Time- and labor- efficient protocol for mouse primary hepatocyte isolation. 1\u201319 (2022).","DOI":"10.3791\/61812-v"},{"key":"75332_CR54","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1039\/b407358d","volume":"3","author":"AC Croce","year":"2004","unstructured":"Croce, A. C. et al. Autofluorescence properties of isolated rat hepatocytes under different metabolic conditions. Photochem. Photobiol. Sci. 3, 920\u2013926 (2004).","journal-title":"Photochem. Photobiol. Sci."},{"key":"75332_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7150\/thno.3463","volume":"2","author":"MK Yu","year":"2012","unstructured":"Yu, M. K., Park, J. & Jon, S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2, 3\u201344 (2012).","journal-title":"Theranostics"},{"key":"75332_CR56","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.mtcomm.2020.101692","volume":"25","author":"R Augustine","year":"2020","unstructured":"Augustine, R. et al. Cellular uptake and retention of nanoparticles: Insights on particle properties and interaction with cellular components. Mater. Today Commun. 25, 101692 (2020).","journal-title":"Mater. Today Commun."},{"key":"75332_CR57","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/toxsci\/kfg064","volume":"73","author":"F Boess","year":"2003","unstructured":"Boess, F. et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: Possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73, 386\u2013402 (2003).","journal-title":"Toxicol. Sci."},{"key":"75332_CR58","unstructured":"Kerimo\u011flu, O., \u00d6zer-\u00f6nder, S., Alar\u00e7in, E. & Karsli, S. Formulation and evaluation of vascular endothelial growth factor loaded polycaprolactone nanoparticles. 1\u201311 (2013)."},{"key":"75332_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12080732","volume":"12","author":"J Weng","year":"2020","unstructured":"Weng, J., Tong, H. H. Y. & Chow, S. F. In vitro release study of the polymeric drug nanoparticles: Development and validation of a novel method. Pharmaceutics 12, 1\u201318 (2020).","journal-title":"Pharmaceutics"},{"key":"75332_CR60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijpharm.2012.05.020","volume":"434","author":"Y Zambito","year":"2012","unstructured":"Zambito, Y., Pedreschi, E. & Di Colo, G. Is dialysis a reliable method for studying drug release from nanoparticulate systems? A case study. Int. J. Pharm. 434, 28\u201334 (2012).","journal-title":"Int. J. Pharm."},{"key":"75332_CR61","doi-asserted-by":"crossref","unstructured":"George, G., Wilson, R. & Joy, J. Ultraviolet Spectroscopy: A Facile Approach for the characterization of nanomaterials. Spectroscopic Methods for Nanomaterials Characterization vol. 2 (Elsevier Inc., (2017).","DOI":"10.1016\/B978-0-323-46140-5.00003-0"},{"key":"75332_CR62","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/adt.2011.391","volume":"10","author":"L Huyck","year":"2012","unstructured":"Huyck, L., Ampe, C. & Van Troys, M. The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix. Assay. Drug Dev. Technol. 10, 382\u2013392 (2012).","journal-title":"Assay. Drug Dev. Technol."},{"key":"75332_CR63","doi-asserted-by":"publisher","unstructured":"Percie, N. et al.  Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","DOI":"10.1371\/journal.pbio.3000411"},{"key":"75332_CR64","unstructured":"Leary, S. et al. AVMA guidelines for the euthanasia of animals: 2020 Edition * (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75332-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75332-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75332-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:04:15Z","timestamp":1729260255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75332-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75332"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75332-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24520"}}